Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
Dec 24, 2024
The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval.
https://www.bizjournals.com/kansascity/news/2024/12/24/cingulate-secures-capital-fda-drug-approval-adhd.html?ana=RSS&s=article_search
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service